Bharat Book Bureau

Archives for Pharma

Engaging KOLs: new thinking on thought leader development Key opinion leaders (KOLs) play a vital role in the effective development and marketing of drugs and medical devices. However, restrictions are increasingly being imposed on the ways in which Medical Science Liaisons (MSLs) and sales reps can access and engage with physicians. Pharma must ensure that… » read more

Posted by bharatbook

New Thinking in Patient Adherence Patient non-adherence is estimated to represent $290 billion per year in avoidable medical expenses in the United States alone. Consumers’ motivations for non-compliance are complex; up to 80% of people are intentionally not taking their prescription drugs as directed. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/new-thinking-in-patient-adherence.html There is no better time for pharma companies to reflect… » read more

Posted by bharatbook

New Thinking in Patient Adherence Patient non-adherence is estimated to represent $290 billion per year in avoidable medical expenses in the United States alone. Consumers’ motivations for non-compliance are complex; up to 80% of people are intentionally not taking their prescription drugs as directed. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/new-thinking-in-patient-adherence.html There is no better time for pharma companies to reflect… » read more

Posted by bharatbook

Pharmacy Retail Market in India 2012 The Pharmacy Retail Market in India is a considerably big market already but has tremendous scope to grow further. Retail pharmacy outlets happens to be the most dominant distribution channel that is responsible for satisfying customer needs of pharmaceutical and allied products directly. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharmacy-retail-market-in-india-2012.html The report begins with the… » read more

Posted by bharatbook

Indian Diagnostic Market Outlook to 2015 In India, the diagnostics sector has been witnessing immense progress in innovative competencies and credibility. Technological advancements and higher efficiency systems are taking the market to new heights. The use of advanced and cutting-edge technologies in understanding a disease prognosis has further strengthened the sophistication level of participants in… » read more

Posted by bharatbook

Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016) The Active Pharmaceutical Ingredient (API) forms the most vital part of every formulated end product, and is an important part of the whole pharmaceutical industry. The overall API market was valued at $101.08 billion in 2010, and is expected to grow at a… » read more

Posted by bharatbook

US Biotech Market Analysis

The US represents the world’s largest biotechnology market, leading with its innovation, extensive R&D, and regular company developments in various spheres of the biotechnology sector. On the back of rising instances of innovations in the information technology, world-class healthcare infrastructure, and active participation by private players, the US biotech industry has grown stupendously in the… » read more

Posted by bharatbook

Partnering Yearbook 2012 The Partnering Yearbook 2012 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2011. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/partnering-yearbook-2012.html * Bigpharma partnering activity during 2011 * Top partnering deals by value in 2011 * Most active dealmakers 2011 * Comprehensive coverage of every… » read more

Posted by bharatbook

Failed launches. It sounds a bit harsh, yet when it comes to new product launches, that has increasingly been the pharmaceutical industry’s experience since the recession. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharma-product-launches-strategies-for-success.html A tighter economic climate, shifting dynamics from prescribers to payers and increased generic competition have all meant that not only are there fewer pipeline drugs, there are fewer… » read more

Posted by bharatbook

“Licensing Activity In Pharmaceutical & Healthcare Industry – Q3 2011” report is an essential source of data and trend analysis on licensing agreements in the pharmaceuticals industry. The report provides detailed information on licensing transactions registered in the pharmaceuticals industry in Q3 2011. http://www.bharatbook.com/detail.asp?id=220358&rt=Licensing-Activity-In-Pharmaceutical-Healthcare-Industry-Q3-2011.html The report provides detailed comparative data on the number of deals… » read more

Posted by bharatbook